miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4

Aims. Fibroblast growth factor receptor 4 (FGFR4) is a key mediator that protects the liver from chronic injury. MicroRNA-7 (miR-7) is a tumor suppressor and associated with lipid homeostasis in the liver. This study was designed to examine the role of the miR-7-5p/FGFR4 axis in liver fibrogenesis....

Full description

Saved in:
Bibliographic Details
Main Authors: Shuxia Tian, Min Chen, Bing Wang, Yonglong Han, Haonan Shang, Junming Chen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2020/5346573
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560159685083136
author Shuxia Tian
Min Chen
Bing Wang
Yonglong Han
Haonan Shang
Junming Chen
author_facet Shuxia Tian
Min Chen
Bing Wang
Yonglong Han
Haonan Shang
Junming Chen
author_sort Shuxia Tian
collection DOAJ
description Aims. Fibroblast growth factor receptor 4 (FGFR4) is a key mediator that protects the liver from chronic injury. MicroRNA-7 (miR-7) is a tumor suppressor and associated with lipid homeostasis in the liver. This study was designed to examine the role of the miR-7-5p/FGFR4 axis in liver fibrogenesis. Methods. TargetScan was employed to predict microRNAs that targeted FGFR4 on the 3′-untranslated region (3′-UTR). miR-7-5p and FGFR4 expression in pathological liver tissues and LX-2 cells was determined using qRT-PCR and an immunoblotting assay. A dual-luciferase assay was conducted to validate the target prediction. A Cell Counting Lit-8 assay was performed to assess the proliferation ability of LX-2 cells. Hydroxyproline content in LX-2 cells was measured using a hydroxyproline assay. The expression of hepatic stellate cell (HSC) activation markers was examined using qRT-PCR and an immunoblotting assay. Results. FGFR4 was a putative target of miR-7-5p. In LX-2 cells, miR-7-5p targeted FGFR4 by binding to 3′-UTR. FGFR4 was downregulated, but miR-7-5p was markedly enhanced in the liver samples as the degree of liver fibrosis rose. miR-7-5p was negatively associated with FGFR4 expression in liver tissues. The miR-7-5p inhibitor blocked the lipopolysaccharide-induced proliferation and activation of LX-2 cells, and FGFR4 overexpression inhibited LX-2 cell proliferation and activation triggered by miR-7-5p. Conclusion. miR-7-5p promotes HSC proliferation and activation by downregulating FGFR4.
format Article
id doaj-art-1475306465294abb81210fb169bf175e
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-1475306465294abb81210fb169bf175e2025-02-03T01:28:10ZengWileyGastroenterology Research and Practice1687-61211687-630X2020-01-01202010.1155/2020/53465735346573miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4Shuxia Tian0Min Chen1Bing Wang2Yonglong Han3Haonan Shang4Junming Chen5Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, ChinaShanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, ChinaShanghai Jiao Tong University Affiliated Sixth People’s Hospital, ChinaShanghai Jiao Tong University Affiliated Sixth People’s Hospital, ChinaShanghai Jiao Tong University Affiliated Sixth People’s Hospital, ChinaShanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, ChinaAims. Fibroblast growth factor receptor 4 (FGFR4) is a key mediator that protects the liver from chronic injury. MicroRNA-7 (miR-7) is a tumor suppressor and associated with lipid homeostasis in the liver. This study was designed to examine the role of the miR-7-5p/FGFR4 axis in liver fibrogenesis. Methods. TargetScan was employed to predict microRNAs that targeted FGFR4 on the 3′-untranslated region (3′-UTR). miR-7-5p and FGFR4 expression in pathological liver tissues and LX-2 cells was determined using qRT-PCR and an immunoblotting assay. A dual-luciferase assay was conducted to validate the target prediction. A Cell Counting Lit-8 assay was performed to assess the proliferation ability of LX-2 cells. Hydroxyproline content in LX-2 cells was measured using a hydroxyproline assay. The expression of hepatic stellate cell (HSC) activation markers was examined using qRT-PCR and an immunoblotting assay. Results. FGFR4 was a putative target of miR-7-5p. In LX-2 cells, miR-7-5p targeted FGFR4 by binding to 3′-UTR. FGFR4 was downregulated, but miR-7-5p was markedly enhanced in the liver samples as the degree of liver fibrosis rose. miR-7-5p was negatively associated with FGFR4 expression in liver tissues. The miR-7-5p inhibitor blocked the lipopolysaccharide-induced proliferation and activation of LX-2 cells, and FGFR4 overexpression inhibited LX-2 cell proliferation and activation triggered by miR-7-5p. Conclusion. miR-7-5p promotes HSC proliferation and activation by downregulating FGFR4.http://dx.doi.org/10.1155/2020/5346573
spellingShingle Shuxia Tian
Min Chen
Bing Wang
Yonglong Han
Haonan Shang
Junming Chen
miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
Gastroenterology Research and Practice
title miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
title_full miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
title_fullStr miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
title_full_unstemmed miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
title_short miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
title_sort mir 7 5p promotes hepatic stellate cell activation by targeting fibroblast growth factor receptor 4
url http://dx.doi.org/10.1155/2020/5346573
work_keys_str_mv AT shuxiatian mir75ppromoteshepaticstellatecellactivationbytargetingfibroblastgrowthfactorreceptor4
AT minchen mir75ppromoteshepaticstellatecellactivationbytargetingfibroblastgrowthfactorreceptor4
AT bingwang mir75ppromoteshepaticstellatecellactivationbytargetingfibroblastgrowthfactorreceptor4
AT yonglonghan mir75ppromoteshepaticstellatecellactivationbytargetingfibroblastgrowthfactorreceptor4
AT haonanshang mir75ppromoteshepaticstellatecellactivationbytargetingfibroblastgrowthfactorreceptor4
AT junmingchen mir75ppromoteshepaticstellatecellactivationbytargetingfibroblastgrowthfactorreceptor4